articleTop 10% cited

The Healthcare Costs of Sarcopenia in the United States

Journal of the American Geriatrics Society · 2003 · Vol. 52(1) · pp. 80–85

Ian Janssen✉(Tufts University)Donald S. Shepard(Brandeis University)Peter T. Katzmarzyk(Brandeis University)Ronenn Roubenoff(Brandeis University)

View via DOI Publisher page

Abstract

Sarcopenia imposes a significant but modifiable economic burden on government-reimbursed healthcare services in the United States. Because the number of older Americans is increasing, the economic costs of sarcopenia will escalate unless effective public health campaigns aimed at reducing the occurrence of sarcopenia are implemented.

Nutrition and Health in Aging Frailty in Older Adults Body Composition Measurement TechniquesSarcopeniaMedicineHealth careNational Health and Nutrition Examination SurveyGerontologyNational Health Interview SurveyPopulationEnvironmental healthPopulation ageing

MeSH terms

Activities of Daily LivingAgedCross-Sectional StudiesHealth ExpendituresFemaleHumansMaleMiddle AgedMuscular AtrophyUnited StatesPrevalenceHealth Care CostsCost of Illness

Citations

1,530

FWCI

7.73

field-weighted impact

References

Percentile

98%

vs. same field & year

Citations per year

Cited by

Imaging of sarcopenia: old evidence and new insights